Chengda Ren
No.301 Middle YanChang Road
Zhabei, 200072, China
Zhabei, 200072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Subretinal Gene Therapy for X-Linked Retinoschisis.
Journal: The New England journal of medicine
Published: June 10, 2026
Lipid Nanoparticle-Delivered mRNA Therapy Corrects Neonatal Murine MPS I-H.
Journal: Human gene therapy
Published: March 26, 2026
Analysis of factors influencing retinal thickness in chronic obstructive pulmonary disease and hypertension: a cross-sectional study in a community-dwelling middle-aged and elderly population.
Journal: Frontiers in medicine
Published: November 23, 2025
RP1 Dual-AAV Gene Therapy Preserves Retinal Structure and Ameliorates Photoreceptor Degeneration in a Murine Model of Retinitis Pigmentosa.
Journal: Investigative ophthalmology & visual science
Published: September 12, 2025
Case Report: Therapeutic biopsy guided targeted therapy improves visual acuity and prolongs survival in bilateral uveal metastases as the initial presentation of lung adenocarcinoma.
Journal: Frontiers in medicine
Published: June 09, 2025
Rescue of neurologic disease in mucopolysaccharidosis type II mice via AAV-mediated liver delivery of brain-penetrating iduronate-2-sulfatase.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 04, 2025
Comparative evaluation of liver-directed knockin strategies with viral and nonviral vectors in mouse inherited disease models.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 29, 2025
AAV-delivered engineered suppressor tRNA rescues visual function in mice with an inherited retinal disease.
Journal: Nature communications
Published: April 02, 2025
Egr1/Gc/vitamin transport axis mediates synergistic effect of macular thinning and underweight in age-related visual acuity decline.
Journal: Experimental eye research
Published: April 01, 2025
Retinal Pigment Epithelium-Targeting Gene Therapy Corrects Ocular Symptoms in Mouse and Rat Models of Oculocutaneous Albinism Type I.
Journal: MedComm
Published: January 26, 2025
ZLN005, a PGC-1α agonist, delays photoreceptor degeneration by enhancing mitochondrial biogenesis in a murine model of retinitis pigmentosa.
Journal: Neuropharmacology
Published: December 02, 2024
Last Updated: 09/26/2026